ACCESS ALS accelerates Canadian ALS research by providing clinics with the tools, training and infrastructure needed to run early-stage, Phase-1 clinical trials.

By building national trial capacity and streamlining access to experimental therapies, we open more opportunities for people living with ALS to participate in cutting-edge studies — and position Canada as a preferred, world-class destination for global ALS research.